-
-
-
-
-
-
-
Raymond James Reiterates Strong Buy Rating on Taysha Gene Therapies (TSHA)
-
-
-
-
-
-
-
Taysha Gene Therapies Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Taysha Gene Therapies to Release Full-Year 2024 Financial Results and Host Conference Call and Webcast on February 26
-
-
-
-
-
-
-
Taysha Gene Therapies (TSHA) Tops Q1 EPS by 1c
-
-
-
-
-
-
-
Taysha Gene Therapies to Release Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 14
-
-
-
-
-
-
-
Taysha Gene Therapies (TSHA) Tops Q1 EPS by 8c
-
-
-
-
-
-
-
Taysha Gene Therapies (TSHA) Tops Q3 EPS by 19c
-
1,217,897 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

